Dibekacin Sulfate

硫酸地贝卡星

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameDibekacin Sulfate
Drug Alias Namedibekacina地贝卡星硫酸盐dibekacinum
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsDacryocystitisBlepharitisKeratitis +[6
Global Approved IndicationsDacryocystitisBlepharitisKeratitis +[6
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1975/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDacryocystitisBlepharitisKeratitis +[6
Inactive IndicationsN/A

Other Information

ATC CodeJ01GB09
Related LinksWikipediaKEGG